Johnson & Johnson (JNJ) Declares $0.95 Quarterly Dividend; 2.8% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
J&J (JNJ), in Response to Report About Criminal Probe in Talc Case, Says Implications There is New Development is Wrong - Reuters
July 12, 2019 12:49 PM EDTJ&J (NYSE: JNJ), in Response to Report About Criminal Probe in Talc Case, Says Implications There is New Development is Wrong - Reuters
Johnson & Johnson (JNJ) Denials of Asbestos in Baby Powder Spur U.S. Criminal Probe - Bloomberg
July 12, 2019 11:44 AM EDT(Updated - July 12, 2019 11:48 AM EDT)
The U.S. Justice Department is pursuing a criminal investigation into whether Johnson & Johnson (NYSE: JNJ) lied to the public about the possible cancer risks of its talcum power, according to Bloomberg, citing people with... More
HIV Vaccine from J&J (JNJ) to Begin Trial in Europe, U.S. This Year - Bloomberg
July 12, 2019 9:53 AM EDTHIV Vaccine from J&J (NYSE: JNJ) to Begin Trial in Europe, U.S. This Year - Bloomberg
Wall St. notches all-time highs on lingering rate-cut optimism
July 12, 2019 7:58 AM EDTBy April Joyner and Caroline Valetkevitch
NEW YORK (Reuters) - All three major indexes posted record closing highs on Friday as firm expectations for an interest-rate cut from the Federal Reserve continued to propel shares while investors awaited next week's kickoff of the corporate earnings season.
The S&P 500 closed above the 3,000 level for the first time, with the industrial , consumer discretionary and materials sectors each posting gains of at least 1%.
In his two-day testimony before Congress, Fed Chairman Jerome Powell said the U.S. economy was still under threat from disappointing... More
Credit Suisse Assumes Johnson & Johnson (JNJ) at Outperform
July 12, 2019 6:30 AM EDTCredit Suisse assumes coverage on Johnson & Johnson (NYSE: JNJ) with a Outperform rating and a price target of $156.00.
For an analyst ratings summary and ratings history on Johnson & Johnson click here. For more ratings news on Johnson & Johnson click here.
Shares of Johnson & Johnson closed at $140.11 yesterday.
... More